UVA research could help identify COVID-19 survivors at risk for long-haul lung problems
UVA Health researchers have discovered a potential way to predict which patients with severe COVID-19 are likely to recover well ...
Tag: Interstitial Lung Disease
Study reveals limited access to pulmonary rehabilitation for millions of Americans
Pulmonary rehabilitation, an essential component of care for patients with chronic respiratory conditions, is difficult for millions of Americans to ...
Study reveals synergistic impact of estrogen and intestinal dysbiosis on pulmonary fibrosis
In a recent study published in Cells, researchers evaluated idiopathic pulmonary fibrosis (IPF) pathophysiological differences by the intestinal microbiome and ...
T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1
Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for ...
Study assesses the prevalence of residual lung abnormalities following COVID-19 hospitalization
In a new study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, researchers ...
Anti-fibrotics found to be safe, effective for interstitial lung disease in patients with rheumatoid arthritis
For the first time, researchers have shown that a class of anti-fibrotic drugs slows the progression of interstitial lung disease ...
